AbbVie Inc. (ETR:4AB)
Germany
· Delayed Price · Currency is EUR 193.38
+3.02 (1.59%)
Feb 21, 2025, 5:35 PM CET
AbbVie Revenue
In the year 2024, AbbVie had annual revenue of $56.33B USD with 3.71% growth. AbbVie had revenue of $15.10B in the quarter ending December 31, 2024, with 5.60% growth.
Revenue
$56.33B
Revenue Growth
+3.71%
P/S Ratio
n/a
Revenue / Employee
$1.02M
Employees
55,000
Market Cap
341.33B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 56.33B | 2.02B | 3.71% |
| Dec 31, 2023 | 54.32B | -3.74B | -6.44% |
| Dec 31, 2022 | 58.05B | 1.86B | 3.30% |
| Dec 31, 2021 | 56.20B | 10.39B | 22.69% |
| Dec 31, 2020 | 45.80B | 12.54B | 37.69% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Siemens Healthineers AG | 22.67B |
| Merck KGaA | 20.96B |
| Bayer Aktiengesellschaft | 46.74B |
| Fresenius SE & Co. KGaA | 22.81B |
| Sartorius Aktiengesellschaft | 3.38B |
| Fresenius Medical Care AG | 19.24B |
| Carl Zeiss Meditec AG | 2.08B |
| Fielmann Group AG | 2.16B |
AbbVie News
- 3 days ago - AbbVie Vs. Johnson & Johnson: Graham Would Prefer The Consumer Healthcare Giant - Seeking Alpha
- 3 days ago - AbbVie Inc. (ABBV) Announces $4 Billion Senior Notes Offering - GuruFocus
- 3 days ago - My Dividend Stock Portfolio: New January Dividend Record - 100 Holdings With 14 Buys - Seeking Alpha
- 3 days ago - Alzamend Neuro Announces Completion of a Novel Head Coil by Tesla for Measuring Brain Structure Lithium Levels in Five Upcoming Phase II Clinical Trials at Massachusetts General Hospital - Business Wire
- 3 days ago - AbbVie Appears Ready To Move Higher - Seeking Alpha
- 5 days ago - How Is The Market Feeling About AbbVie? - Benzinga
- 8 days ago - AbbVie Names CEO Robert A. Michael as Next Chairman - CEOWORLD magazine
- 8 days ago - AbbVie: An Undervalued Dividend Aristocrat - Seeking Alpha